Abstract:AimRecent studies indicate that pirfenidone (PFD) may have anti-fibrotic effects in many tissues, but the potential molecular mechanism remains unknown. The purpose of this study is to investigate the potential effects of PFD on epithelial-to-mesenchymal transition (EMT) and renal fibrosis in a unilateral ureteral obstruction (UUO) rat model and the involved molecular mechanism related to cultured human renal proximal tubular epithelial cells (HK-2). MethodsSixty rats were randomly divided into three groups: sham-operated, vehicle-treated UUO, and PFD-treated UUO. Kidney specimens were collected at day 7 or 14 after UUO. PFD treatment was also performed for human HK-2. The tubulointerstitial injury, interstitial collagen deposition, and expression of type I and III collagen, -SMA, S100A4, fibronection and E-cadherin were assessed. In addition, extracellular signal regulated kinase (ERK1/2), p38 MAPK (p38), and c-Jun N-terminal kinase/stress-activated protein kinase (JNK) were also detected. ResultsIn vitro, PFD significantly attenuated TGF-1-induced EMT and extracellular matrix (ECM) synthesis, as determined by reducing expression of -SMA, type I and III collagen, S100A4, fibronection, and increased expression of E-cadherin. PFD treatment attenuated TGF-1-induced up-regulation of phosphorylation of ERK1/2, p38 and JNK. In vivo, PFD reduced the degree of tubulointerstitial injury and renal fibrosis, which was associated with reduced expression of TGF-1, type III collagen, -SMA, S100A4, fibronection, and increased expression of E-cadherin. ConclusionThese results suggest that pirfenidone is able to attenuate EMT and fibrosis in vivo and in vitro through antagonizing the MAPK pathway, providing a potential treatment to alleviate renal tubulointerstitial fibrosis. Summary at a Glance This study demonstrated the efficacy of the pirfenidone to improve renal fibrosis in both an experimental rodent model, UUO and on epithelial-to-mesenchymal transition and fibrotic markers in cultured human proximal tubular cells. Pirfenidone is an anti-fibrotic drug used in the treatment of idiopathic pulmonary fibrosis. Hence pirfenidone could be further investigated as a potential treatment to alleviate renal tubulointerstitial fibrosis.

Periplaneta Americana Extract May Attenuate Renal Fibrosis through Inhibiting Janus Tyrosine Kinase 2/Signal Transducer and Activator of Transcription 3 Pathway

Pomolic Acid Ameliorates Fibroblast Activation and Renal Interstitial Fibrosis through Inhibition of SMAD-STAT Signaling Pathways

Periplaneta americana extract attenuates hepatic fibrosis progression by inhibiting collagen synthesis and regulating the TGF-β1/Smad signaling pathway

Pirfenidone Suppresses MAPK Signalling Pathway to Reverse Epithelial-Mesenchymal Transition and Renal Fibrosis

Natural Flavonoid Pectolinarigenin Alleviated Kidney Fibrosis Via Inhibiting the Activation of TGFβ/SMAD3 and JAK2/STAT3 Signaling.

Aloe-Emodin Ameliorates Renal Fibrosis Via Inhibiting PI3K/Akt/mTOR Signaling PathwayIn VivoandIn Vitro

Aloe-Emodin Ameliorates Renal Fibrosis Via Inhibiting PI3K/Akt/mTOR Signaling Pathway In Vivo and In Vitro

PTEN Improve Renal Fibrosis in Vitro and in Vivo Through Inhibiting FAK/AKT Signaling Pathway

Paeoniflorin of Paeonia Lactiflora Prevents Renal Interstitial Fibrosis Induced by Unilateral Ureteral Obstruction in Mice

Paeonol Ameliorates Diabetic Renal Fibrosis Through Promoting the Activation of the Nrf2/ARE Pathway Via Up-Regulating Sirt1

Asiatic Acid Prevents Renal Fibrosis in UUO Rats Via Promoting the Production of 15D-Pgj2, an Endogenous Ligand of PPAR-γ

Poricoic Acid A Attenuates Renal Fibrosis by Inhibiting Endoplasmic Reticulum Stress-Mediated Apoptosis

Blocking Protein Phosphatase 2A Signaling Prevents Endothelial-to-mesenchymal Transition and Renal Fibrosis: a Peptide-Based Drug Therapy

Fluorofenidone Attenuates Tubulointerstitial Fibrosis by Inhibiting TGF-β1-Induced Fibroblast Activation

N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Attenuates Renal Inflammation And Tubulointerstitial Fibrosis In Rats

Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting β-catenin K49 deacetylation

Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation

The novel peptide PEP-Z-2 potentially treats renal fibrosis in vivo and in vitro by regulating TGF-β/Smad/AKT/MAPK signaling

Beclin-1-Derived - Derived Peptide MP1 Attenuates Renal Fibrosis by Inhibiting the Wnt//3-Catenin /3-Catenin PathwayS S

P0704PROTECTIVE EFFECT OF DUAL ACTING LIGAND TARGETING A2A AND A3 ADENOSINE RECEPTOR ON OBSTRUCTION-INDUCED KIDNEY INJURY IN MICE

Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy Via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways